Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Blunt

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Brain Research|November 14, 1998
Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatumJ Opacka-Juffry, A W Wilson, S B Blunt
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesionsK P Datla, S B Blunt, D T Dexter
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Facial myokymia in multiple system atrophyS B Blunt, N M Khalil, G D Perkin
The European Journal of Neuroscience|September 30, 1998
Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivoA M Sullivan, J Opacka-Juffry, S B Blunt
Archives of Disease in Childhood|January 24, 2020
Neonatal early onset sepsis in Middle Eastern countries: a systematic reviewNadim Khalil, Heather B Blunt, Zhongze Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's diseaseR B Banati, S E Daniel, S B Blunt
Brain Research|January 23, 1999
Neuroprotective effects of growth/differentiation factor 5 depend on the site of administrationA M Sullivan, J Opacka-Juffry, J Pohl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
Clinical features and management of two cases of encephalitis lethargicaS B Blunt, R J Lane, N Turjanski, et al.
The American Journal of Drug and Alcohol Abuse|June 1, 1991
Amnestic effects of intravenous diazepam in healthy young menR M Anthenelli, M G Monteiro, B Blunt, et al.
The Quarterly Journal of Medicine|November 1, 1990
An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findingsS B Blunt, L M Sandler, J M Burrin, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Brain Research|November 14, 1998
Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatumJ Opacka-Juffry, A W Wilson, S B Blunt
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesionsK P Datla, S B Blunt, D T Dexter
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Facial myokymia in multiple system atrophyS B Blunt, N M Khalil, G D Perkin
The European Journal of Neuroscience|September 30, 1998
Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivoA M Sullivan, J Opacka-Juffry, S B Blunt
Archives of Disease in Childhood|January 24, 2020
Neonatal early onset sepsis in Middle Eastern countries: a systematic reviewNadim Khalil, Heather B Blunt, Zhongze Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's diseaseR B Banati, S E Daniel, S B Blunt
Brain Research|January 23, 1999
Neuroprotective effects of growth/differentiation factor 5 depend on the site of administrationA M Sullivan, J Opacka-Juffry, J Pohl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
Clinical features and management of two cases of encephalitis lethargicaS B Blunt, R J Lane, N Turjanski, et al.
The American Journal of Drug and Alcohol Abuse|June 1, 1991
Amnestic effects of intravenous diazepam in healthy young menR M Anthenelli, M G Monteiro, B Blunt, et al.
The Quarterly Journal of Medicine|November 1, 1990
An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findingsS B Blunt, L M Sandler, J M Burrin, et al.
Pageof 5